Litcius/Paper detail

Diagnostic testing for SARS-CoV-2

Carl Boodman, Philippe Lagacé‐Wiens, Jared Bullard

2020Canadian Medical Association Journal71 citationsDOIOpen Access PDF

Abstract

Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relies on reverse transcription polymerase chain reaction (RT-PCR), which amplifies SARS-CoV-2 genetic material.[1][1] Nasopharyngeal or oropharyngeal RT-PCR sensitivity is highest when performed early after symptom onset.[2][2

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePolymerase chain reactionCoronavirus disease 2019 (COVID-19)Reverse transcription polymerase chain reaction2019-20 coronavirus outbreakBetacoronavirusCoronavirusVirologySars virusBiologyInternal medicineGeneGeneticsDiseaseInfectious disease (medical specialty)Messenger RNAOutbreakSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology